Literature DB >> 19092466

Ten years follow-up after deep sclerectomy with collagen implant.

Alexandre Bissig1, Delphine Rivier, Marc Zaninetti, Tarek Shaarawy, André Mermoud, Sylvain Roy.   

Abstract

PURPOSE: To evaluate the long-term success rate and complications of nonpenetrating deep sclerectomy with collagen implant in open-angle glaucoma. PATIENTS AND METHODS: Clinical, prospective, monocentric, nonrandomized, unmasked study on 105 patients with medically uncontrolled glaucoma. A standard procedure deep sclerectomy with collagen implant was performed. Complete examinations were performed before surgery and postoperatively at 1 and 7 days; 1, 2, 3, 6, 9, and 12 months and then every 6 months during the 10 following years.
RESULTS: The mean follow-up was 101.5+/-43.1 (3 to 144) months [mean+/-SD, (range)]. The preoperative intraocular pressure (IOP) was 26.8+/-7.7 (14 to 52) mm Hg and the best-corrected visual acuity 0.71+/-0.33 (0.02 to 1.5). Ten years after surgery IOP was 12.2+/-4.7 (6 to 20) mm Hg and best-corrected visual acuity 0.63+/-0.34 (0.01 to 1.2) (number of remaining patients=52). The mean number of medications per patient went from 2.3+/-0.7 (1 to 4) down to 1.3+/-1.1 (0 to 3). An IOP <or=21 mm Hg without medication was achieved in 47.7% patients and in 89% with or without treatment. One major complication was reported. Goniopuncture was performed in 61 eyes (59.8%), 5-fluorouracil treatment given to 25 patients postoperatively and included needling (n=5).
CONCLUSIONS: On the basis of a 10-year follow-up deep sclerectomy with collagen implant demonstrated its efficacy in controlling IOP with few postoperative complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19092466     DOI: 10.1097/IJG.0b013e318182ed9e

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  25 in total

1.  IOP-lowering effects for the application of human umbilical vein in non-penetrating deep sclerostomy in rabbits.

Authors:  Yang Yang; Yu Di; Dong-Mei Gui; Zhi-Li Liu; Xin Liu; Dian-Wen Gao
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

2.  Migration of reticulated hyaluronic acid implant [SK-GEL] following deep sclerectomy.

Authors:  Saleh A Al Obeidan
Journal:  Int Ophthalmol       Date:  2009-10-22       Impact factor: 2.031

3.  Long-term efficacy of deep sclerectomy in Posner-Schlossman syndrome.

Authors:  Fiamma Campana; Guido Caramello; Laura Dallorto; Teresa Rolle
Journal:  BMJ Case Rep       Date:  2015-01-23

4.  [Deep sclerectomy. An alternative to trabeculectomy].

Authors:  M Klemm
Journal:  Ophthalmologe       Date:  2015-04       Impact factor: 1.059

Review 5.  [Treatment of postoperative endophthalmitis : Operate or only inject?]

Authors:  L Mautone; C Skevas; M S Spitzer
Journal:  Ophthalmologe       Date:  2021-02-10       Impact factor: 1.059

6.  Three-year canaloplasty outcomes for the treatment of open-angle glaucoma: European study results.

Authors:  Holger Bull; Kurt von Wolff; Norbert Körber; Manfred Tetz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-06       Impact factor: 3.117

7.  Prospective evaluation of CO2 laser-assisted sclerectomy surgery (CLASS) with Mitomycin C.

Authors:  Carlo Alberto Cutolo; Alessandro Bagnis; Riccardo Scotto; Chiara Bonzano; Carlo Enrico Traverso
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-17       Impact factor: 3.117

8.  A modified deep sclerectomy with or without external trabeculectomy: a comparative study.

Authors:  George Kitsos; Miltiades Aspiotis; Yannis Alamanos; Konstantinos Psilas
Journal:  Clin Ophthalmol       Date:  2010-06-24

9.  Deep sclerectomy: safety and efficacy.

Authors:  Zsolt Varga; Tarek Shaarawy
Journal:  Middle East Afr J Ophthalmol       Date:  2009-07

10.  Results of a modified non-penetrating deep sclerectomy in the treatment of open angle glaucoma with or without cataract.

Authors:  George Kitsos; Miltiades Aspiotis; Yannis Alamanos; Konstantinos Psilas
Journal:  Clin Ophthalmol       Date:  2010-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.